Neuralink's Breakthrough: FDA Approval for Human Trials Marks a Milestone in Brain-Computer Interface Technology
In a groundbreaking development, Neuralink, the brainchild of tech entrepreneur Elon Musk, received FDA approval for its first human clinical trial back in May. This pivotal moment represents a giant leap forward in the field of brain-computer interfaces (BCIs). Neuralink's mission to merge technology with the human brain has garnered immense attention, and this approval signifies a major step towards making this vision a reality. Image source : Jagran Josh Unlocking the Potential: Neuralink's Vision Neuralink's ambitious goal is to enhance human capabilities by creating a direct connection between the human brain and computers. At the core of this technology is the N1 implant, a device powered by a wireless-charging battery. This implant comprises 64 flexible threads, finer than a human hair, strategically placed in the part of the brain responsible for "movement intention." These threads enable the recording and wireless transmission of brain signals to an app, ...